Search HDBuzz

Double success for huntingtin RNAi gene silencing

Double success for huntingtin RNAi gene silencing

2 bits of good news for RNAi gene silencing in HD: it's safe over six months, and a way to treat bigger brain areas

Professor Ed WildJanuary 24, 2012

HD Therapeutics Conference 2012 Updates: Day 1

HD Therapeutics Conference 2012 Updates: Day 1

Day 1 of our coverage of the Huntington's Disease Therapeutics Conference

Dr Jeff CarrollFebruary 29, 2012

HD Therapeutics Conference 2012 Updates: Day 2

HD Therapeutics Conference 2012 Updates: Day 2

Day 2 of our coverage of the Huntington's Disease Therapeutics Conference

Professor Ed WildMarch 01, 2012

HD Therapeutics Conference 2012 Updates: Day 3

HD Therapeutics Conference 2012 Updates: Day 3

Day 3 of our coverage of the Huntington's Disease Therapeutics Conference

Dr Jeff CarrollMarch 02, 2012

Mutant yeast highlights crucial CAG-reading protein

Mutant yeast highlights crucial CAG-reading protein

A new job for a DNA-reading protein called SPT4 - controlling the balance of mutant and healthy huntingtin protein

Professor Ed WildMarch 14, 2012

2012 Therapeutics Conference: a retrospective

2012 Therapeutics Conference: a retrospective

HDBuzz looks back at the 2012 Huntington's Disease Therapeutics Conference

Professor Ed WildApril 03, 2012

Exercise increases cellular recycling

Exercise increases cellular recycling

Exercise boosts cellular recycling in mice. Could this be why exercise is also good for HD – or even help develop dru

Dr Tony HannanMay 11, 2012

Interview: CHDI's scientific team

Interview: CHDI's scientific team

HDBuzz interviews the top scientists from CHDI, the largest funder of Huntington's disease research in the world.

Professor Ed WildMay 18, 2012

Phosphodiesterase inhibitors: new HD drugs entering trials soon

Phosphodiesterase inhibitors: new HD drugs entering trials soon

CHDI and Pfizer announce exciting animal work and plans for a human trial with a drug targeting 'phosphodiesterases'.

Carly DesmondJune 07, 2012

ASO gene silencing reaches further, lasts longer

ASO gene silencing reaches further, lasts longer

Silencing the Huntingtin gene using ASO drugs reaches further, lasts longer and is safe. Human trial soon?

Dr Nayana LahiriJune 21, 2012

You can also read About HDBuzz for information on HDBuzz or try your search on a search engine.

Donate

Please consider making a donation if you value the services that HDBuzz provides. We want HDBuzz to be sustainable so that we can continue to report unbiased science to the HD community.

With your support, we can ensure the continuity of our services. Nothing is expected, but everything is appreciated and sustains what we do at HDBuzz. Please consider giving what you're able. More information...